# Wrap Technologies, Inc.: overview WRAP · Nasdaq · CIK 1702924 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/wrap.md) · [Financials](/companies/wrap/financials.md) · [Filings](/companies/wrap/filings.md) · [Insiders](/companies/wrap/insiders.md) Latest reported revenue: [$2.1m](/filings/0001140361-26-032276.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:Revenues, accession 0001140361-26-032276). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [593](/filings/0001140361-25-041816.md) | [865 d](/filings/0001140361-26-011401.md) | [765](/filings/0001140361-26-021091.md) | [1,012](/filings/0001140361-26-032276.md) | [1,491](/filings/0001140361-25-041816.md) | [1,404 d](/filings/0001140361-26-011401.md) | [1,111](/filings/0001140361-26-021091.md) | [2,052](/filings/0001140361-26-032276.md) | | Gross margin | % | [39.6%](/filings/0001140361-25-041816.md) | [47.4% d](/filings/0001140361-26-011401.md) | [77.8%](/filings/0001140361-26-021091.md) | [48.1%](/filings/0001140361-26-032276.md) | [59.2%](/filings/0001140361-25-041816.md) | [52.3% d](/filings/0001140361-26-011401.md) | [62.2%](/filings/0001140361-26-021091.md) | [75.3%](/filings/0001140361-26-032276.md) | | Operating margin | % | [(611.5%)](/filings/0001140361-25-041816.md) | [(535.6%) d](/filings/0001140361-26-011401.md) | [(512.7%)](/filings/0001140361-26-021091.md) | [(282.2%)](/filings/0001140361-26-032276.md) | [(185.2%)](/filings/0001140361-25-041816.md) | [(280.9%) d](/filings/0001140361-26-011401.md) | [(429.3%)](/filings/0001140361-26-021091.md) | [(109.7%)](/filings/0001140361-26-032276.md) | | Net margin | % | [335.6%](/filings/0001140361-25-041816.md) | [(878.3%) d](/filings/0001140361-26-011401.md) | [14.2%](/filings/0001140361-26-032276.md) | [(368.3%)](/filings/0001140361-26-032276.md) | [(186.0%)](/filings/0001140361-25-041816.md) | [(280.9%) d](/filings/0001140361-26-011401.md) | [(408.6%)](/filings/0001140361-26-032276.md) | [(110.0%)](/filings/0001140361-26-032276.md) | | Diluted EPS | $ per share | [0.04](/filings/0001140361-25-041816.md) | not reported | [0.00](/filings/0001140361-26-021091.md) | [(0.07)](/filings/0001140361-26-032276.md) | [(0.06)](/filings/0001140361-25-041816.md) | not reported | [(0.09)](/filings/0001140361-26-021091.md) | [(0.04)](/filings/0001140361-26-032276.md) | | Free cash flow | $k | [330 d](/filings/0001140361-25-041816.md) | [(1,207) d](/filings/0001140361-26-011401.md) | [(3,071)](/filings/0001140361-26-021091.md) | [(1,946) d](/filings/0001140361-26-032276.md) | [(2,700) d](/filings/0001140361-25-041816.md) | [(2,672) d](/filings/0001140361-26-011401.md) | [(1,251)](/filings/0001140361-26-021091.md) | [(2,439) d](/filings/0001140361-26-032276.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [7.7](/filings/0001437749-23-005218.md) | [8.0](/filings/0001437749-24-027942.md) | [6.1](/filings/0001641172-25-001416.md) | [4.5](/filings/0001140361-26-011401.md) | [4.7](/filings/0001140361-26-011401.md) | | Gross margin | % | [25.8%](/filings/0001437749-23-005218.md) | [46.4%](/filings/0001437749-24-027942.md) | [47.4%](/filings/0001641172-25-001416.md) | [54.7%](/filings/0001140361-26-011401.md) | [57.8%](/filings/0001140361-26-011401.md) | | Operating margin | % | [(316.9%)](/filings/0001437749-23-005218.md) | [(220.3%)](/filings/0001437749-24-027942.md) | [(305.3%)](/filings/0001641172-25-001416.md) | [(345.4%)](/filings/0001140361-26-011401.md) | [(288.6%)](/filings/0001140361-26-011401.md) | | Net margin | % | [(316.3%)](/filings/0001437749-23-005218.md) | [(218.9%)](/filings/0001437749-24-027942.md) | [(492.7%)](/filings/0001641172-25-001416.md) | [(130.4%)](/filings/0001140361-26-011401.md) | [(221.2%)](/filings/0001140361-26-011401.md) | | Diluted EPS | $ per share | [(0.62)](/filings/0001851734-22-000144.md) | not reported | [(0.72)](/filings/0001641172-25-001416.md) | [(0.16)](/filings/0001140361-26-011401.md) | [(0.22)](/filings/0001140361-26-011401.md) | | Free cash flow | $m | [(19.2)](/filings/0001437749-23-005218.md) | [(14.9)](/filings/0001437749-24-027942.md) | [(16.9)](/filings/0001641172-25-001416.md) | [(8.1)](/filings/0001140361-26-011401.md) | [(10.4)](/filings/0001140361-26-011401.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/wrap/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.0m | 1,547,010 | | Added +7,872 | | [RAYMOND JAMES FINANCIAL INC](/funds/720005.md) | 2026-06-30 | $881.6k | 683,397 | | Reduced −8,176 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $734.5k | 569,372 | | Added +44,674 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $558.7k | 432,841 | | Reduced −38,977 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $461.9k | 358,100 | | Added +41,338 | | [Caption Management, LLC](/funds/1706766.md) | 2026-06-30 | $326.0k | 252,700 | Call | Reduced −222,300 | | [Platform Technology Partners](/funds/1830817.md) | 2026-06-30 | $302.6k | 234,607 | | New +234,607 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $286.7k | 222,269 | | Added +1,542 | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $261.2k | 202,484 | | Reduced −2,111 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $210.4k | 163,077 | | Added +57,968 | ## Recent filings [All 566 filings](/companies/wrap/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-26 | 16:05 ET | [8-K](/filings/0001493152-26-048510.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-048510 | | 2026-09-09 | 17:14 ET | [8-K](/filings/0001493152-26-041992.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-041992 | | 2026-08-18 | 17:13 ET | [8-K](/filings/0001493152-26-039044.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-039044 | | 2026-08-18 | 09:19 ET | [8-K](/filings/0001493152-26-038916.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-038916 | | 2026-08-11 | 17:20 ET | [10-Q](/filings/0001140361-26-032276.md) | Quarterly report, period 2026-06-30 | 0001140361-26-032276 | | 2026-08-11 | 16:15 ET | [8-K](/filings/0001493152-26-037136.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037136 | | 2026-07-13 | 17:09 ET | [8-K](/filings/0001493152-26-033073.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-033073 | | 2026-05-13 | 17:06 ET | [10-Q](/filings/0001140361-26-021091.md) | Quarterly report, period 2026-03-31 | 0001140361-26-021091 | | 2026-05-13 | 16:20 ET | [8-K](/filings/0001493152-26-022738.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022738 | | 2026-03-26 | 17:05 ET | [10-K](/filings/0001140361-26-011401.md) | Annual report, period 2025-12-31 | 0001140361-26-011401 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001140361-26-011401.md), filed Mar 26, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/0fb329b0-66aa-4185-b24f-cfc71245cb8b) ## About the filer - CIK: 1702924 - Tickers: WRAP - Exchange: Nasdaq - SIC code: 3480 Ordnance & Accessories, (No Vehicles/Guided Missiles) - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:01 ET. No prices; not investment advice.